AbCellera Biologics Inc. has grown revenue −24% a year over three years and −29% a year over five. Revenue growth, 3-year annual rate: −24% (Biotechnology median +21%). Revenue growth, 5-year rate: −29%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

ABCLAbCellera Biologics Inc.

HealthcareUSD

$12.24

$2.7852 weeks$12.50

Is it growing?

Is ABCL growing?

AbCellera Biologics Inc. has grown revenue −24% a year over three years and −29% a year over five.

−24%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −29%
Revenue growth, 5-year rate · −24% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›